The efficacy of HRAS and CDK4/6 inhibitors in anaplastic thyroid cancer cell lines. [electronic resource]
Producer: 20190820Description: 527-540 p. digitalISSN:- 1720-8386
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis
- Cell Cycle
- Cell Proliferation
- Cyclin-Dependent Kinase 4 -- antagonists & inhibitors
- Cyclin-Dependent Kinase 6 -- antagonists & inhibitors
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Mutation
- Piperazines -- administration & dosage
- Proto-Oncogene Proteins p21(ras) -- antagonists & inhibitors
- Pyridines -- administration & dosage
- Quinolones -- administration & dosage
- Thyroid Carcinoma, Anaplastic -- drug therapy
- Thyroid Neoplasms -- drug therapy
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.